The advance represents a giant step forward in the ability to generate new, endogenous cartilage tissue, researchers at Sahlgrenska Academy in Sweden said.
In future, it should be possible to use 3D bioprinting to generate cartilage based on a patient's own, "backed-up" stem cells, they said.
"This bioprinted tissue can be used to repair cartilage damage, or to treat osteoarthritis, in which joint cartilage degenerates and breaks down," researchers wrote in the study published in the journal Scientific Reports.
The research team was able to influence the cells to multiply and differentiate to form chondrocytes (cartilage cells) in the printed structure.
More From This Section
The team used cartilage cells harvested from patients who underwent knee surgery, and these cells were then manipulated in a laboratory, causing them to rejuvenate and revert into "pluripotent" stem cells - cells that have the potential to develop into many different types of cells.
The stem cells were then expanded and encapsulated in a composition of nanofibrillated cellulose and printed into a structure using a 3D bioprinter.
Following printing, the stem cells were treated with growth factors that caused them to differentiate correctly, so that they formed cartilage tissue.
"We are the first to succeed with it, and we did so without any animal testing whatsoever," said Simonsson.
Each individual stem cell is encased in nanocellulose, which allows it to survive the process of being printed into a 3D structure.
The cartilage formed by the stem cells in the 3D bioprinted structure is extremely similar to human cartilage.
Experienced surgeons who examined the artificial cartilage saw no difference when they compared the bioprinted tissue to real cartilage, and have stated that the material has properties similar to their patients' natural cartilage, researchers said.